Skip to main content

Statutary Instruments

Volume 403: debated on Tuesday 8 April 2003

The text on this page has been created from Hansard archive content, it may contain typographical errors.

To ask the Chancellor of the Exchequer if he will list the statutory instruments issued by his Department in the last 12 months, indicating (a) the purpose of each and (b) the cost of each to (i) public funds, (ii) businesses and (iii) individuals. [106318]

The HMSO SI Registrar ( can provide a list of statutory instruments that have been issued by individual Government Departments. SIs which have been originated by Departments but eventually made by the Privy Council are only listed under the Privy Council Office. Many of the SIs introduced were of a routine nature, for example approving annual fee increases.The costs associated with regulatory proposals are considered at the policy development stage. A regulatory impact assessment is completed for regulatory proposals unless there are no or negligible costs. HM Treasury, HM Customs and HM Inland Revenue have produced twenty full/final regulatory impact assessments in this period. These RIAs listed below are available from the House Libraries and are available on departmental websites:

Custom and Excise RIAs

VAT Flat Rate Scheme and Changes to the Annual Accounting Scheme; Oils Fraud Strategy.


The money laundering regulations 2001; The protection of the euro against counterfeiting regulations 2001; Financial Services and Markets Act 2002 (administration orders relating to insurers) Order 2002; E-commerce directive; Fourth motor insurance directive; Electric communication for building societies; Amending the Credit Unions Act 1997.

Inland Revenue RIAs

ISAS—Simplified Voiding for Investor Error; Tax Law Rewrite Project—Income Tax (Earnings and Pensions) Bill; The New Tax Credits; National Insurance Contributions Bill; Fuel Scale Charge; Reform of the Taxation of Intangible Assets; Construction Industry Scheme Research and Development Tax Credits for Large Companies/Vaccines Research Relief; Exemptions for Gains and Losses on Substantial Shareholdings; Reform of the Corporate Debt, Financial Instruments and Foreign Exchange Gains and Losses Regimes; Community Amateur Sports Club.